To better understand the role of SOCE in other LPMC subsets besides T cells, we analyzed the effects of BTP2 treatment on the expression of cytokines and cell surface molecules by CD45+CD3−non‐T cells, in particular B cells and myeloid cells, among LPMCs of the same IBD patients (Fig 2G, Appendix Fig S5). This evidence concerns the gene PTPRC and inflammatory bowel disease.